Correlation Between Edwards Lifesciences and Fresenius Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edwards Lifesciences and Fresenius Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edwards Lifesciences and Fresenius Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edwards Lifesciences Corp and Fresenius Medical Care, you can compare the effects of market volatilities on Edwards Lifesciences and Fresenius Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edwards Lifesciences with a short position of Fresenius Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edwards Lifesciences and Fresenius Medical.

Diversification Opportunities for Edwards Lifesciences and Fresenius Medical

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Edwards and Fresenius is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Edwards Lifesciences Corp and Fresenius Medical Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fresenius Medical Care and Edwards Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edwards Lifesciences Corp are associated (or correlated) with Fresenius Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fresenius Medical Care has no effect on the direction of Edwards Lifesciences i.e., Edwards Lifesciences and Fresenius Medical go up and down completely randomly.

Pair Corralation between Edwards Lifesciences and Fresenius Medical

Allowing for the 90-day total investment horizon Edwards Lifesciences Corp is expected to generate 0.94 times more return on investment than Fresenius Medical. However, Edwards Lifesciences Corp is 1.06 times less risky than Fresenius Medical. It trades about 0.14 of its potential returns per unit of risk. Fresenius Medical Care is currently generating about 0.08 per unit of risk. If you would invest  6,541  in Edwards Lifesciences Corp on September 25, 2024 and sell it today you would earn a total of  940.00  from holding Edwards Lifesciences Corp or generate 14.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Edwards Lifesciences Corp  vs.  Fresenius Medical Care

 Performance 
       Timeline  
Edwards Lifesciences Corp 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences Corp are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Edwards Lifesciences showed solid returns over the last few months and may actually be approaching a breakup point.
Fresenius Medical Care 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Fresenius Medical Care are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain primary indicators, Fresenius Medical may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Edwards Lifesciences and Fresenius Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edwards Lifesciences and Fresenius Medical

The main advantage of trading using opposite Edwards Lifesciences and Fresenius Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edwards Lifesciences position performs unexpectedly, Fresenius Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fresenius Medical will offset losses from the drop in Fresenius Medical's long position.
The idea behind Edwards Lifesciences Corp and Fresenius Medical Care pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios